Clinical trial
A Study of Picoplatin in Colorectal Cancer
NCT00478946 · Poniard Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00478946 |
|---|---|
| Title | A Study of Picoplatin in Colorectal Cancer |
| Official title | A Phase I Open-Label Study of Picoplatin in Combination With 5-Fluorouracil and Leucovorin as Initial Therapy in Subjects With Metastatic Colorectal Cancer |
| Lead sponsor | Poniard Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | (FOLPI) Picoplatin with 5-FU and Leucovorin, FOLPI, FOLFOX |
| Enrollment | 43 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | May 25, 2007 |
| Last update posted | Jan 21, 2009 |
| Countries | Russia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: